2021
DOI: 10.1016/j.lungcan.2021.04.010
|View full text |Cite
|
Sign up to set email alerts
|

Long-term survival and recurrence after resection of bronchopulmonary carcinoids: A single-center cohort study of 236 patients

Abstract: The aim of this study was to determine overall survival and recurrence-free survival after resection of bronchopulmonary carcinoids by means of predominantly minimally invasive surgery and lung-sparing resections. In addition, we aimed to identify prognostic factors for overall survival. Materials and methods: Retrospective review of consecutive patients operated for bronchopulmonary carcinoids between January 2009 and October 2020 identified from a prospectively collected database. Results: A total of 236 pat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 18 publications
(5 citation statements)
references
References 49 publications
0
5
0
Order By: Relevance
“…The World Health Organization (WHO) classification of 2021 includes low- and intermediate-grade typical carcinoid and AC, respectively, and high-grade carcinomas, such as SCLC [ 3 ]. Carcinoid tumors represent approximately 1–3% of all primary lung neoplasms, ACs being the least common and having worst prognosis compared to typical carcinoids [ 4 ]. However, the 5-year survival rate is overall higher for carcinoid tumors compared to SCLC, regardless of their stage [ 5 ].…”
Section: Discussionmentioning
confidence: 99%
“…The World Health Organization (WHO) classification of 2021 includes low- and intermediate-grade typical carcinoid and AC, respectively, and high-grade carcinomas, such as SCLC [ 3 ]. Carcinoid tumors represent approximately 1–3% of all primary lung neoplasms, ACs being the least common and having worst prognosis compared to typical carcinoids [ 4 ]. However, the 5-year survival rate is overall higher for carcinoid tumors compared to SCLC, regardless of their stage [ 5 ].…”
Section: Discussionmentioning
confidence: 99%
“…Surgically fit patients with localized L-NENs should be managed with radical resection and systematic nodal dissection. The most important objective is a microscopically tumor-free resection margin (R0), which is associated with a good prognosis and the best outcomes in all subtypes [ 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 , 62 , 63 ]. The 10 year survival rate for TC is more than 90% in lymph node-negative disease (N0) and is still up to 75% if either hilar (N1) or mediastinal (N2) lymph nodes are affected.…”
Section: Treatment Optionsmentioning
confidence: 99%
“…Individuals diagnosed with atypical carcinoids should undergo at least a lobectomy as a basic surgical intervention [58,61,87]. Nowadays, most surgeries for lung carcinoids are performed by video-assisted thoracoscopic surgery (VATS) [88], which leads to better quality of life as well as better-preserved lung and shoulder function compared with open surgery [89]. Even if there is a small risk for conversion to open surgery, especially in larger tumors, this does not result in more postoperative complications [90].…”
Section: Surgerymentioning
confidence: 99%